Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: The Role of Amylin and Glucagon in T1DM [Phase 3]
A Phase 3 trial evaluating the roles of amylin and glucagon in Type 1 diabetes mellitus has completed. The update summarizes the trial statu…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes [Phase 3]
Phase 3 trial update on prolonged pramlintide infusion in pediatric Type 1 diabetes mellitus; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Continuous Subcutaneous Infusion of Pramlintide and Insulin [Phase 4]
Phase 4 trial evaluating continuous subcutaneous infusion of pramlintide with insulin in Type 1 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Lunch Time Insulin Injection by School Nurse for Poorly Controlled Diabetes [Phase 4]
Phase 4 trial evaluating lunch-time insulin injections administered by a school nurse for children with poorly controlled type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Lantus in the Treatment of Type 1 Diabetes Children [Phase 4]
Phase 4 trial evaluating Lantus (insulin glargine) in children with Type 1 Diabetes has been completed. The study was sponsored by Baylor Co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-07-08FDA Approved: TRESIBA — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Tresiba (insulin degludec) from Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes [Phase 1]
A Phase 1 study evaluating the acute metabolic effects of exenatide in Type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes [Phase 4]
Phase 4 clinical trial evaluating Onglyza (saxagliptin) for effects on glucose fluctuation and immune regulation in patients with Type 1 dia…
-
CLINICAL_TRIALS research · 2016-06-28Clinical Trial Update: Analysis of Viral Infections' Exposition Preceding the Type 1 Diabetes (T1D) Diagnostic in Children of the Isis-Diab Cohort. Search for Explanations of of the Disease's Early Onset
This clinical trial update analyzes whether exposure to viral infections occurs before the diagnosis of Type 1 diabetes mellitus in children…
-
CLINICAL_TRIALS research · 2016-06-28Clinical Trial Update: Genetic and Environmental Risk Factors of Type 1 Autoimmune Diabetes and Its Early Complications
A clinical trial update examining genetic and environmental risk factors for Type 1 diabetes mellitus and its early complications.
-
FDA label_change · 2016-06-24FDA Approved: TRESIBA — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Tresiba (insulin degludec) from Novo Nordisk, resulting in a labeling change.
-
CLINICAL_TRIALS withdrawal · 2016-06-23Clinical Trial Update: A Performance Evaluation of the Enlite 3 Sensor [NA]
An evaluation trial for the Enlite 3 continuous glucose monitoring sensor in Type 1 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-06-21Clinical Trial Update: The Impact of Continuous Glucose Monitoring Use on Sleep in Parents of Children With Type 1 Diabetes Mellitus
Clinical trial NCT01425255 evaluating continuous glucose monitoring and sleep in parents of children with Type 1 diabetes mellitus has been …
-
FDA approval · 2016-06-17FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for BASAGLAR KWIKPEN (insulin glargine) by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2016-06-15Clinical Trial Update: Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon [Phase 2]
This Phase 2 trial evaluated the pharmacokinetics and pharmacodynamics of a single subcutaneous dose of ZP4207 in hypoglycemic Type 1 diabet…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation [Phase 2]
A Phase 2 study assessed the safety implications of overestimating the meal insulin bolus within a dual-hormone closed-loop system in indivi…
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus [Phase 1, Phase 2]
The study reports completion of Phase 1 and Phase 2 clinical trials evaluating intravenous alpha-1 antitrypsin for safety and efficacy in in…
-
CLINICAL_TRIALS research · 2016-06-09Clinical Trial Update: Patient With Any Pathology (According to the Appreciation of the Investigator) Which Could Disturb the Participation in the Study [NA]
A clinical trial update for a pediatric Type 1 diabetes study notes that a patient whose pathology could disturb participation may affect en…
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients [Phase 3]
A Phase 3 efficacy trial of DiaPep277 in newly diagnosed Type 1 Diabetes patients has completed and results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes [Phase 3]
Phase 3 trial results evaluating the efficacy and safety of liraglutide as an adjunct to insulin in adults with type 1 diabetes; the study h…
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Pet Ownership and Glucose Control in Type 1 Diabetes [NA]
This completed clinical trial updates findings on whether pet ownership influences glucose control in people with Type 1 Diabetes.
-
CLINICAL_TRIALS research · 2016-06-02Clinical Trial Update: Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials [NA]
A completed update describing methodological approaches to improve how metabolic assessments are conducted in Type 1 diabetes clinical trial…
-
FDA approval · 2016-06-01FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for BASAGLAR KWIKPEN (insulin glargine) filed by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression [Phase 2]
Phase 2 results of islet transplantation in people with Type 1 diabetes using the Edmonton Protocol with steroid-free immunosuppression have…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Influence of Vitamin D on Vascular Function in Adolescents and Young Adults With Type 1 Diabetes [Phase 2]
Phase 2 trial assessing whether vitamin D supplementation influences vascular function in adolescents and young adults with Type 1 diabetes.…